Find Federal Grants
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MH-21-151
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional)
National Institutes of Health · RFA-MH-21-150
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)
National Institutes of Health · PAR-21-081
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
Centers for Disease Control and Prevention - ERA · RFA-IP-21-002
Health Resources and Services Administration · HRSA-21-041
Building Capacity to Improve Collecting and Reporting Viral Suppression Data to the Medicaid Adult Core Set
Health Resources and Services Administration · HRSA-21-083
Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional)
National Institutes of Health · RFA-DK-20-033
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
National Institutes of Health · PA-21-071
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
National Institutes of Health · PAR-21-023
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
National Institutes of Health · PAR-21-022
Strengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globally
Centers for Disease Control and Prevention - ERA · RFA-GH-21-006
Promoting the Importance of Infant and Childhood Vaccination Among Pregnant Women by Prenatal Care Providers
Centers for Disease Control and Prevention - ERA · RFA-IP-21-001
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional)
National Institutes of Health · RFA-MH-21-111
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MH-21-110
National Institutes of Health · PAR-21-072
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-21-053
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
National Institutes of Health · PAR-21-045
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional)
National Institutes of Health · RFA-MH-21-112
National Institutes of Health · PAR-21-070
Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-20-030